Research Article
New Personal Model for Forecasting the Outcome of Patients with Histological Grade III-IV Colorectal Cancer Based on Regional Lymph Nodes
Table 2
The univariate and multivariate logistic regression analysis of overall survival in the training cohort.
| Variates | Univariate logistic regression analysis | LASSO-logistic regression analysis | OR | 2.5% CI | 97.5% CI | value | OR | 2.5% CI | 97.5% CI | value |
| Age | <45 years old | Reference | | | | Reference | | | | 45–60 years old | 1.070 | 0.921 | 1.240 | 0.385 | 1.222 | 1.022 | 1.463 | 0.029 | >60 years old | 1.290 | 1.120 | 1.490 | <0.001 | 1.994 | 1.677 | 2.375 | <0.001 | Sex | Male | Reference | | | | Reference | | | | Female | 0.890 | 0.820 | 0.965 | 0.005 | 0.859 | 0.778 | 0.948 | 0.003 | Race | White | Reference | | | | Reference | | | | Black | 1.230 | 1.080 | 1.400 | 0.002 | 1.242 | 1.063 | 1.451 | 0.006 | Other | 0.904 | 0.781 | 1.050 | 0.173 | 0.926 | 0.776 | 1.103 | 0.389 | Primary site | Left colon | Reference | | | | Reference | | | | Right colon | 1.180 | 1.070 | 1.300 | 0.001 | 1.302 | 1.152 | 1.473 | <0.001 | Rectum | 0.812 | 0.717 | 0.918 | 0.001 | 1.119 | 0.964 | 1.300 | 0.140 | Pathology grade | Grade III | Reference | | | | | | | | Grade IV | 1.270 | 1.140 | 1.410 | <0.001 | | | | | AJCC T stage | T1 | Reference | | | | Reference | | | | T2 | 1.540 | 1.100 | 2.140 | 0.012 | 1.403 | 0.993 | 2.002 | 0.058 | T3 | 4.420 | 3.350 | 5.840 | <0.001 | 2.391 | 1.789 | 3.251 | <0.001 | T4 | 14.100 | 10.700 | 18.700 | <0.001 | 5.145 | 3.821 | 7.046 | <0.001 | AJCC N stage | N0 | Reference | | | | Reference | | | | N1 | 2.630 | 2.350 | 2.950 | <0.001 | 0.963 | 0.788 | 1.176 | 0.714 | N2 | 6.720 | 6.020 | 7.510 | <0.001 | 1.018 | 0.796 | 1.302 | 0.884 | AJCC M stage | M0 | Reference | | | | Reference | | | | M1 | 9.470 | 8.470 | 10.600 | <0.001 | 3.674 | 3.068 | 4.412 | <0.001 | Histological type | Adenocarcinoma | Reference | | | | Reference | | | | AM/MPA | 1.510 | 1.310 | 1.730 | <0.001 | 1.214 | 1.029 | 1.432 | 0.021 | SRCC | 2.220 | 1.830 | 2.690 | <0.001 | 1.637 | 1.301 | 2.061 | <0.001 | LNR | Low | Reference | | | | Reference | | | | High | 5.470 | 4.990 | 6.000 | <0.001 | 1.174 | 0.609 | 2.241 | 0.629 | LODDS | LODDS1 | Reference | | | | Reference | | | | LODDS2 | 2.630 | 2.340 | 2.950 | <0.001 | 1.897 | 1.553 | 2.32 | <0.001 | LODDS3 | 9.400 | 8.370 | 10.600 | <0.001 | 3.092 | 1.587 | 6.078 | 0.001 | Examined lymph nodes | Low | Reference | | | | | | | | High | 0.563 | 0.494 | 0.641 | <0.001 | | | | | Negative lymph nodes | Low | Reference | | | | Reference | | | | High | 0.225 | 0.203 | 0.248 | <0.001 | 0.583 | 0.505 | 0.674 | <0.001 | Metastasis at bone | No | Reference | | | | Reference | | | | Yes | 38.700 | 12.200 | 123.000 | <0.001 | 5.852 | 2.110 | 24.349 | 0.003 | Metastasis at brain | No | Reference | | | | | | | | Yes | 6.370 | 2.600 | 15.600 | <0.001 | | | | | Metastasis at liver | No | Reference | | | | | | | | Yes | 8.430 | 7.350 | 9.670 | <0.001 | | | | | Metastasis at lung | No | Reference | | | | Reference | | | | Yes | 6.880 | 5.100 | 9.290 | <0.001 | 1.794 | 1.439 | 2.234 | <0.001 |
|
|
AJCC, American Joint Committee on Cancer; T, tumor; N, nodes; M, metastasis; LNR, Lymph node ratio; AM/MPA, mucinous adenocarcinoma\mucin-producing adenocarcinoma; SRCC, signet ring cell carcinoma; OR, odds ratio; CI, confidence interval.
|